SMC-MR deletion mitigated obesity-associated cardiac and coronary inflammation and dysfunction, but not hypertrophy, potentially involving reduced cardiac mast cells and enhanced SMC estrogen signaling that warrant further investigation. This evidence concerns the gene NR3C2 and Obesity.